CCS
PRLB icon

Crosspoint Capital Strategies’s Protolabs PRLB Stock Holding History

Crosspoint Capital Strategies’s Portfolio PRLB Stock Details PRLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-39
Closed -$3K – 637
2015
Q4 		$3K Buy
+39
New +$2.52K ﹤0.01% 880

Other funds holding PRLB

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACA
Abdiel Capital Advisors New York $52M AUM 13.8% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Crosspoint Capital Strategies's PRLB Position: Q1 2016 in Review

Crosspoint Capital Strategies sold out of Protolabs (PRLB) in Q1 2016, closing a stake of 39 shares — an estimated $3K sold.

Crosspoint Capital Strategies first reported a position in PRLB in Q4 2015 and held it in 1 quarter. The position peaked at $3K in Q4 2015. 211 funds tracked by Wall St. Rank hold PRLB as of Q1 2016.

  • Crosspoint Capital Strategies reported no remaining Protolabs position as of Q1 2016 after selling out during the quarter.
  • Crosspoint Capital Strategies sold 39 Protolabs shares in Q1 2016, an estimated $3K.
  • Crosspoint Capital Strategies first reported a position in Protolabs in Q4 2015 and held it in 1 quarter.
  • Crosspoint Capital Strategies's Protolabs position peaked at $3K in Q4 2015.
  • 211 funds tracked by Wall St. Rank held Protolabs as of Q1 2016.

Based on Crosspoint Capital Strategies's 13F filing for Q1 2016, filed 16 May 2016.